Enovis

Enovis EBITDA per Share

The EBITDA per Share of Enovis (ENOV) as of Oct 19, 2026 is -0.33 USD. In the previous year, EBITDA per Share was -7.33 USD — a change of -95.47% (higher).

EBITDA per Share

-0.33USD

YoY

-95.47%

Last updated:

EBITDA per Share of Enovis is 2025 -0.33 USD. EBITDA per Share of Enovis was 2024 -7.33 USD. It decreases by -95.47% higher compared to the previous year.

The Enovis EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
8.39 USD
Jan 1, 2019
6.53 USD
Jan 1, 2020
6.95 USD
Jan 1, 2021
0.85 USD
Jan 1, 2022
3.48 USD
Jan 1, 2023
4.15 USD
Jan 1, 2024
-7.33 USD
Jan 1, 2025
-0.33 USD
The Enovis EBITDA per Share history
YEAREBITDA per ShareYoY
-0.33USD-95.47%
-7.33USD-276.92%
4.15USD+19.06%
3.48USD+308.03%
0.85USD-87.72%
6.95USD+6.50%
6.53USD-22.18%
8.39USD+403.42%
1.67USD-76.80%
7.18USD+4.37%
6.88USD-29.91%
9.82USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Enovis Stock analysis

What does Enovis do? Enovis Corp, listed on the stock market with ticker ENOV and ISIN US1940145022, is a health care company headquartered in Wilmington, United States. The company has 7,802 employees and went public on May 8, 2008. Enovis operates within the health care sector, focusing on medical technology and the development of clinically differentiated solutions. The company manufactures and distributes medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. It functions through two operational segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment offers products including rigid bracing, orthopedic soft goods, vascular systems, compression garments, and hot and cold therapy solutions, alongside recovery sciences products such as bone growth stimulators and electrical stimulators for clinical rehabilitation and sports medicine. The Reconstructive segment specializes in knee, hip, shoulder, elbow, foot, ankle, and finger implant products, as well as surgical productivity solutions. Additionally, Enovis provides Novastep, a minimally invasive surgery solution for foot and ankle procedures. The company's website is www.enovis.com. Enovis Corp is engaged in the production and distribution of medical devices aimed at improving patient outcomes through innovative technology and solutions in the health care industry. Enovis is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enovis stock

EBITDA per Share of Enovis is -0.33 USD in 2025.

EBITDA per Share of Enovis changed from -7.33 USD to -0.33 USD, representing a -95.47% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Enovis since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Enovis

All Key Metrics — Enovis